Treatment Duration

How long do people take Suboxone?

There's no universal answer — but most guidelines recommend at least a year, and many people do well on longer treatment. Here's what the evidence actually says.

All topics

Looking for treatment? Same-day visits usually available. No insurance required.

Call or text Schedule online →

How long should someone stay on Suboxone?

People often ask this in two ways: how long people typically stay on Suboxone, and how long they personally should remain on it.

The answer is the same — it is individualized.

How long someone stays on Suboxone treatment depends on clinical stability, risk of return to use, and what is happening in their life — not a fixed timeline.

Most people who do well on Suboxone treatment remain on it for an extended period. Some stop. Many do not.

There is no required cutoff. There is no standard Suboxone schedule, no set course, and no single Suboxone therapy duration that applies to everyone.

What guidelines say

There are no recommended time limits.

SAMHSA and ASAM — the two primary bodies setting addiction medicine standards — both advise against arbitrary limits on buprenorphine treatment. The duration of treatment is individualized. No suboxone timeline applies universally.

The older model — a short treatment period followed by discontinuation — is no longer considered evidence-based. Opioid use disorder is a chronic condition. Buprenorphine treatment for opioid use disorder is not time-limited in the way earlier models assumed.

Stopping medication prematurely produces outcomes similar to stopping treatment for other chronic conditions.

A 2020 study in JAMA Psychiatry found that patients who remained on buprenorphine had lower rates of overdose and emergency care use compared to those who discontinued.

What determines duration

What determines how long someone stays on Suboxone?

Several factors influence Suboxone maintenance duration:

Stability and life context

Housing, employment, and support systems. Patients in unstable or high-risk environments generally benefit from continuing medication.

Length and severity of opioid use

Longer histories often benefit from longer treatment. Prior return to use after stopping is a key clinical factor.

Co-occurring conditions

Depression, anxiety, PTSD, and related conditions increase return to use risk. These factors directly influence Suboxone therapy duration decisions.

Patient preference

A planned taper differs from stopping due to external pressure. Patient preference is a clinical variable.

Is there a standard Suboxone duration?

No.

There is no evidence-based point at which Suboxone treatment must be stopped.

Short courses are associated with worse outcomes. Longer treatment is associated with better outcomes.

Many patients remain on buprenorphine long-term as part of standard care.

Stopping Suboxone treatment

Stopping is not the goal of treatment.

Buprenorphine does not need to be tapered simply because a patient has been stable.

If tapering is considered, it is a clinical decision. When appropriate, it is gradual — not abrupt.

Suboxone withdrawal from buprenorphine is milder than withdrawal from full opioid agonists, but it can still be uncomfortable and prolonged.

Suboxone withdrawal duration depends on dose, duration of use, and how gradually the taper is done.

Suboxone effects during withdrawal are best managed with a slow taper — dose reductions over weeks or months rather than days.

Stopping abruptly significantly increases the risk of return to use.

A structured taper plan is safer than stopping independently. That discussion happens with your physician.

Related questions

How long does buprenorphine take to work →

How to start Suboxone treatment →

How Suboxone treatment is structured →

Sources

Where this information comes from.

Clinical guideline

ASAM National Practice Guideline (2023)

Updated ASAM guidance on duration of buprenorphine treatment, tapering, and individualized care planning.

Federal guidance

SAMHSA TIP 63: Medications for Opioid Use Disorder

Federal clinical guidelines on buprenorphine treatment length, patient selection, and tapering protocols.

Research

Wakeman et al., JAMA Psychiatry (2020)

Comparative effectiveness study showing reduced overdose and emergency visits among patients who remained on buprenorphine treatment.

Federal guidance

HHS: Opioid Treatment Resources

Federal treatment resource hub including medication-assisted treatment guidance and patient support tools.

Related

← All Learn topics  ·  How long Suboxone lasts (pharmacology)  ·  Starting Suboxone  ·  How long does buprenorphine take to work?  ·  How to get Suboxone online

MyStreetHealth serves

Virginia  ·  Maryland  ·  Washington DC  ·  West Virginia  ·  Ohio

Common questions

Frequently asked

Is there a maximum time you can take Suboxone?

No. There's no medically established maximum. Buprenorphine is safe for long-term use and current guidelines do not recommend time limits on treatment.

What happens if I stop Suboxone suddenly?

Stopping abruptly can cause withdrawal symptoms and significantly raises return to use risk. A supervised, gradual taper is always the safer approach. Talk to your physician before making any changes.

How do I know when I'm ready to taper?

Readiness for tapering is a clinical conversation — not something with a simple checklist. Stability in housing, relationships, mental health, and absence of cravings are relevant factors. Your prescriber can help you assess where you are.

Does insurance limit how long I can get Suboxone?

Some insurers have historically imposed limits, but federal parity laws and updated guidance have reduced this significantly. MyStreetHealth operates on a self-pay model, so insurance restrictions don't apply to care through us.

Also on this site

Questions about treatment?

Same-day visits usually available.

(888) 835-9995 · Call or text Schedule online →
Home Our approach Services Care fees Pay what you can FAQ Science Learn Locations Patient portal Call (888) 835-9995